CPRX vs TECH · P/E 18, rev $491.7M vs P/E 65, rev $1.22B
Catalyst Pharmaceuticals Inc (CPRX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CPRX currently screens at market cap $3.84B and trailing P/E 18.2. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CPRX and TECH stock pages for the full models.
Not investment advice.